Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
Plos One|March 20, 2012
Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brainKoichi Suenaga, Kuang-Yung Lee, Masayuki Nakamori, et al.
Journal of Clinical Medicine|November 27, 2025
Plasma Neurofilament Light Chain and Phosphorylated Tau Are Elevated in Myotonic Dystrophy Type 1Masanori P Takahashi, Harutsugu Tatebe, Hiroto Takada, et al.
Scientific Reports|February 18, 2017
Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instabilityJunko Ueki, Masayuki Nakamori, Masahiro Nakamura, et al.
Eclinicalmedicine|February 5, 2024
Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialMasayuki Nakamori, Daisaku Nakatani, Tomoharu Sato, et al.
Brain Communications|October 2, 2020
Hypokalaemic periodic paralysis with a charge-retaining substitution in the voltage sensorTomoya Kubota, Fenfen Wu, Savine Vicart, et al.
Elife|December 13, 2019
<i>Straightjacket/α2δ3</i> deregulation is associated with cardiac conduction defects in myotonic dystrophy type 1Emilie Auxerre-Plantié, Masayuki Nakamori, Yoan Renaud, et al.
European Heart Journal Open|October 11, 2024
CTG repeat length underlying cardiac events and sudden death in myotonic dystrophy type 1Hideki Itoh, Takashi Hisamatsu, Kazuhiko Segawa, et al.
Scientific Reports|July 23, 2013
Ultrasound-enhanced delivery of morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model miceMichinori Koebis, Tamami Kiyatake, Hiroshi Yamaura, et al.
Journal of the American Heart Association|August 20, 2020
Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1Hideki Itoh, Takashi Hisamatsu, Takuhisa Tamura, et al.
Pageof 15